Seeking Alpha

FBT
First Trust Amex Biotechnology Index ETF

5/26/2012, 7:52 AM ET
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
FBT Market Currents more »
  • May 14 Biotech ETFs are near all-time highs despite overall market weakness, due to successful trials - e.g. for Vertex's (VRTX) cystic fibrosis treatment - and because some investors are betting on deals occurring. One ETF that is doing particularly well this year is iShares Nasdaq Biotech (IBB). Others include XBI, FBT and BBH. [Healthcare]
ETF Stats
  • Expense Ratio: 0.60%
  • Average Bid Ask Ratio: 0.11%
  • Tracking Error: 0.19%
  • Concentration Risk: 9.97%
  • Capital Gains Dist. %: 0.00%
  • Number of Securities: 20
  • Dividend Amount:
  • Dividend Date:
For overall rating and ranking versus other ETFs get a free trial to XTF Premium
FBT News more »
Currently, there are no news on FBT.
FBT Press Releases and Filings more »
Currently, there are no press releases or filings on FBT.
FBT Cramer more »
Currently, there are no Cramer articles on FBT.
FBT Instablog posts more »
  • TOP 5 BIOTECH ETFs
    Wed, Feb 15 David Fry Comment!
  • It Ain't Over Til The Market Says So - July 7, 2011
    Thu, Jul 7, 2011 Morpheus Trading Group Comment!
  • Strategies for Pending Biotech Correction
    Mon, Jun 6, 2011 Justin M. Hall Comment!
  • Five ETFs to Watch This Week
    Tue, Feb 16, 2010 Don Dion Comment!
Write a post on FBT
FBT StockTalks
FBT vs. ETF Alternatives
FBT Description
The First Trust NYSE Arca Biotechnology Index Fund is and exchange-traded index fund. The investment objective of the fund is to replicate as closely as possible, before fees and expenses, the price and yield of the NYSE Arca Biotechnology IndexSM. The NYSE Arca Biotechnology IndexSM is an equal dollar weighted index designed to measure the performance of a cross section of companies in the biotechnology industry that are primarily involved in the use of biological processes to develop products or provide services. Such processes include, but are not limited to, recombinant DNA technology, molecular biology, genetic engineering, monoclonal antibody-based technology, lipid/liposome technology, and genomics. he index is rebalanced quarterly based on closing prices on the third Friday in January, April, July & October to ensure that each component stock continues to represent approximately equal weight in the index.
See more details on sponsor's website
Sector: Healthcare
Country: United States
Key Info